Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 366.57B, Merck(MRK) trades at $148.58. The stock has a price-to-earnings ratio of 112.64 and currently yields dividends of 2.41%.
On 2026-10-29, Merck(MRK) stock traded between a low of $143.31 and a high of $149.12. Shares are currently priced at $148.58, which is +3.7% above the low and -0.4% below the high.
Merck(MRK) shares are trading with a volume of 1.48M, against a daily average of 11.23M.
During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.
During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.
MRK News
Merck & Co (MRK) shares rose 2.14% in Thursday premarket trading after the drugmaker beat third-quarter Wall Street estimates and raised its full-year adjusted...
Merck & Co. reported higher revenue in the latest quarter. Ralph Orlowski / REUTERS Merck MRK -0.63 %decrease; down pointing triangle & Co. reported higher rev...
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Merck on Thursday topped third-quarter estimates and hiked its...
Analyst ratings
68%
of 31 ratingsMore MRK News
Pharmaceutical giants Merck (MRK) and Eli Lilly (LLY) are scheduled to report third-quarter results on October 29, with analysts expecting a year-on-year earnin...
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brok...
Merck (NYSE:MRK) reported new Phase 3 data for sacituzumab tirumotecan and KEYTRUDA in advanced or recurrent endometrial cancer, highlighted at a major oncology...
Merck & Co. Inc. (NYSE:MRK) on Monday announced results from two late-stage clinical studies evaluating treatments for advanced or recurrent endometrial cancer...
The upcoming report from Merck (MRK Quick QuoteMRK - Free Report) is expected to reveal quarterly earnings of $2.12 per share, indicating a decline of 17...
Merck and Moderna reported detailed Phase 3 INTerpath-001 results showing that personalized mRNA therapy intismeran plus Keytruda cut recurrence or death risk b...
has delivered a powerful multi year share price run and a packed oncology news flow, which naturally raises a simple question for you as an investor. Is the cur...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.